Hi. Good evening. Just can you take us through some changes in the working capital? Saw some little deterioration in terms of receivables and payables. Just can you elaborate what has happened in this particular half?
And payable?
Questions across 4 calls
Amit Kadam
Canara Robeco Mutual Fund
Torrent Pharmaceuticals Limited
The Indian Hotels Company Limited
Three questions from my end. First is just one observation from the presentation, Slide number 35. I see some churning in Vivanta's portfolio in terms of ope rational rooms where the latest number is 3,681 versus last quarter, what we have seen almost like 4,062. Any specific reason for this particular churn? That's question number one. Second is just like in the managed fees, we have reported other fees as INR10 crores. Can you just throw some light what is it about? So that's question two. And third is just like a in terms of as we are focusing more on managed hotels. Is there a change in the I would say, profit share in that particular maybe the percentage of revenue, what we have seen in last couple of years or may see in future? Yes, that's it.
The question was on -- in the managed fee section, you have reported for the quarter INR177 crores. In this particular slide only, you have reported INR10 crores as other fees, which have been observing for the first time, hence wanted some more color.
Max Healthcare Institute Limited
Just couple of things , the swing what we saw in the inpatient volumes this quarter, largely you attributed to the vector borne disease , just wanted to know because we have a very limited understanding like in last three years or so, we haven't seen such kind of large swing because the b ed days for this quarter is -1%. So, can you just throw from your past experience we had seen such kind of large swing which could have a material impact on the inpatient volumes, and which could result in bed days?
Yes. No, I was just not contesting your that particular point. I just wanted to know because we have a very limited history because we got, so from the data point we did not have, I did not have the insight that whether such kind of some seasonality, when I'm talking seasonality, I'm trying to compare Y-o-Y because of some like vector borne disease, we have a material impact on the volume growth Y-o-Y. I can understand how Q2 to Q3 seasonality works. But I was just saying in the past history whether such kind of events like vector borne is not there, could have a material impact on the volume growth just wanted to.
Piramal Pharma Limited
So, my first question is that as the business recovers and it's clearly showing in the numbers, what is still a weakling in that overall business which warrants management attention? And that's point number one . It may be also like some kind of industry some breathing headwinds . Something on that also will be very helpful. The second question is that employee cost is a significant part of our business . It still like sequentially went up. Any ballpark maybe number in terms of like how do we build it in terms of going forward? And what should be the correct base? So, that's another point.
But still like can you be clearer like on this part and how do we see this thing? Because here I see that we had a like the number what we are in terms of 27% of our top line are now employee cost. We used to operate at much lower. Maybe operating leverage is something which is still yet to be played out, but that's what I wanted to see. Because from where I am trying to come is that maybe few years back, because our resources are also internationally based, 2%, 3% kind of inflation based maybe hikes would have been a case and b allpark we could have built 5 %, 6% as a n incremental maybe cost going in this particular, but as the overall interest rate itself globally has moved up, the expectation for salary hikes are also up. So, just wanted to know should we consider at like 8%, 9% as an annual increase on a base what maybe on whatever we form in FY '24 ? Is that a way of building a few things or how the management is looking forward? Because it's a significant number to our overall things, scheme of things in bring maybe operating leveraged things to kick in.